| Dr Denise M Donahue, MD | |
|
301 S 7th Ave, Suite 3220, West Reading, PA 19611-1410 | |
| (610) 376-8671 | |
| (610) 376-6387 |
| Full Name | Dr Denise M Donahue |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 41 Years |
| Location | 301 S 7th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518091867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD033596E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Keystone Orthopaedic Specialists, Llc | 2062547920 | 25 |
News Archive
As Congress returns from its August recess for what promises to be a dramatic health care finale, a few papers offer refreshers on what's contained in the bills lawmakers and the president are preparing to debate, and how they will affect millions of citizens. Three news reports compare key proposals, and suggest key questions for reformers.
House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) in a recent letter warned four pharmaceutical companies to end the use of "misleading and deceptive" direct-to-consumer advertisements for medications, CQ HealthBeat reports.
Historically, authorities have used broad media campaigns to encourage the public to prepare for disasters - an approach that has proven largely ineffective. For this new study, UCLA researchers sought to test novel, culturally tailored, informal social networking approaches to improve disaster preparedness, using data on 231 Hispanics in Los Angeles County.
With growing concern that excessive levels of fructose may pose a great health risk - causing high blood pressure, kidney disease and diabetes - researchers at the University of Colorado School of Medicine, along with their colleagues at the University of Florida, set out to see if two common sweeteners in western diets differ in their effects on the body in the first few hours after ingestion.
Dyax Corp. and CMIC Co., Ltd, announced today an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE) and other angioedema indications in Japan.
› Verified 3 days ago
| Entity Name | Keystone Orthopaedic Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255666012 PECOS PAC ID: 2062547920 Enrollment ID: O20100317000260 |
News Archive
As Congress returns from its August recess for what promises to be a dramatic health care finale, a few papers offer refreshers on what's contained in the bills lawmakers and the president are preparing to debate, and how they will affect millions of citizens. Three news reports compare key proposals, and suggest key questions for reformers.
House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) in a recent letter warned four pharmaceutical companies to end the use of "misleading and deceptive" direct-to-consumer advertisements for medications, CQ HealthBeat reports.
Historically, authorities have used broad media campaigns to encourage the public to prepare for disasters - an approach that has proven largely ineffective. For this new study, UCLA researchers sought to test novel, culturally tailored, informal social networking approaches to improve disaster preparedness, using data on 231 Hispanics in Los Angeles County.
With growing concern that excessive levels of fructose may pose a great health risk - causing high blood pressure, kidney disease and diabetes - researchers at the University of Colorado School of Medicine, along with their colleagues at the University of Florida, set out to see if two common sweeteners in western diets differ in their effects on the body in the first few hours after ingestion.
Dyax Corp. and CMIC Co., Ltd, announced today an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE) and other angioedema indications in Japan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Denise M Donahue, MD 301 S 7th Ave, Suite 3220, West Reading, PA 19611-1410 Ph: (610) 376-8671 | Dr Denise M Donahue, MD 301 S 7th Ave, Suite 3220, West Reading, PA 19611-1410 Ph: (610) 376-8671 |
News Archive
As Congress returns from its August recess for what promises to be a dramatic health care finale, a few papers offer refreshers on what's contained in the bills lawmakers and the president are preparing to debate, and how they will affect millions of citizens. Three news reports compare key proposals, and suggest key questions for reformers.
House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) in a recent letter warned four pharmaceutical companies to end the use of "misleading and deceptive" direct-to-consumer advertisements for medications, CQ HealthBeat reports.
Historically, authorities have used broad media campaigns to encourage the public to prepare for disasters - an approach that has proven largely ineffective. For this new study, UCLA researchers sought to test novel, culturally tailored, informal social networking approaches to improve disaster preparedness, using data on 231 Hispanics in Los Angeles County.
With growing concern that excessive levels of fructose may pose a great health risk - causing high blood pressure, kidney disease and diabetes - researchers at the University of Colorado School of Medicine, along with their colleagues at the University of Florida, set out to see if two common sweeteners in western diets differ in their effects on the body in the first few hours after ingestion.
Dyax Corp. and CMIC Co., Ltd, announced today an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE) and other angioedema indications in Japan.
› Verified 3 days ago
Dr. Kenneth John Mcalpine Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 365, West Reading, PA 19611 Phone: 484-628-2663 Fax: 484-628-2621 | |
Dr. John D Casey, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 S 7th Ave, Suite 3220, West Reading, PA 19611 Phone: 610-376-8671 Fax: 610-376-6387 | |
Dr. Eric Michael Slotkin, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 3220, West Reading, PA 19611 Phone: 610-376-8671 Fax: 610-376-6387 | |
Dr. Joseph M Scornavacchi Jr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 S 7th Ave, Suite 3220, West Reading, PA 19611 Phone: 610-376-8671 Fax: 610-376-6387 | |
Nathan Tiedeken, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 365, West Reading, PA 19611 Phone: 570-624-4777 Fax: 570-624-4778 | |
Dr. Stephen C Longenecker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 365, West Reading, PA 19611 Phone: 484-628-2663 Fax: 484-628-2621 |